True Science Backed
by Pharmaceutical Standards of Research, Development and Measurable
Results Creates a Quantum Leap Forward in Finer Skin Care
Dermazone Solutions is an acknowledged
leader in the field of nanotechnology and holds patents on its
proprietary nanosphere delivery system, Lyphazome®, in twenty
countries worldwide. Celazome® cosmeceutical skincare products,
available through physicians and aestheticians, provide solutions
to Protect, Correct, Perfect, and Respect, whether you need to
safeguard from sun exposure, fix problematic conditions like acne
or rosacea, minimize fine lines and wrinkles, or simply highlight
your skin's best assets. Our sunscreens and therapeutic lotions
have been marketed to physicians, hospitals and professional caregivers
throughout the U.S. for more than fourteen years.
Dermazone markets its products outside the U.S. directly or through
exclusive distributors. Currently, Dermazone products are available
in Brazil, Russia, New Zealand, Japan, Hong Kong, Macau, Kuwait,
Belgium, Denmark, Holland, Portugal and Italy..
Dermazone licenses its formulas and technology
through exclusive partnership agreements.
Our Lyphazome Technology and formulas have successfully built
brands for  several
business partners over the years.
Product Development
with One Clear Focus: Industry-leading Results
- Formulas - Using only the finest
ingredients at their optimum levels and delivered via our Lyphazome
nanospheres, Celazome products achieve astonishing results visible
in three weeks or less for most people.
- Delivery - At 1/50th
the size of a human skin cell, Lyphazome nanospheres penetrate
deep into the epidermis, providing moisture and ingredients
where they can be most effective.
- Concentration - Dermazone's
nanotechnology formulas feature at least 80 percent Lyphazome
nanospheres loaded with bioactives and moisture-75 times the
concentration found in other encapsulation products.
- Sustained Release - Lyphazome
nanospheres penetrate deep, slowly releasing ingredients for
continuous, long-lasting care, while non-encapsulated ingredients
begin releasing bioactive ingredients on the surface of the
skin for immediate benefits.
- Testing - Dermazone applies
pharmaceutical standards for guaranteed quality, and all products
are clinically tested and proven to remain stable and active
for two years after manufacture date.
- Research - More than thirteen
years of research and product development continue in our on-site
laboratories.
- Reputation - Leading dermatologists,
plastic surgeons, aestheticians, podiatrists, hospitals and
spas around the world recommend and sell Dermazone products.
Patents
for Lyphazome Technology
Dermazone currently holds patents for its
Lyphazome nanotechnology, also known as Solvent Dilution MicroCarrier
(SDMC), in the following counties:
Country
|
Patent No.
|
|
U.S. |
5,879,703 and 5,269,979 |
|
Australia |
6,77826 |
|
Canada |
Pending |
European Convention including:
Austria, Belgium, Denmark ,France, Great Britain,
Germany, Italy, Netherlands, Portugal, Singapore, Spain, Sweden,
Switzerland |
688206 |
|
